Back to Journals » ClinicoEconomics and Outcomes Research » Volume 17 » default
ClinicoEconomics and Outcomes Research
- View all (1022)
- Volume 18, 2026 (38)
- Volume 17, 2025 (73)
- Volume 16, 2024 (62)
- Volume 15, 2023 (67)
- Volume 14, 2022 (61)
- Volume 13, 2021 (90)
- Volume 12, 2020 (70)
- Volume 11, 2019 (71)
- Volume 10, 2018 (77)
- Volume 9, 2017 (77)
- Volume 8, 2016 (73)
- Volume 7, 2015 (64)
- Volume 6, 2014 (53)
- Volume 5, 2013 (59)
- Volume 4, 2012 (41)
- Volume 3, 2011 (19)
- Volume 2, 2010 (16)
- Volume 1, 2009 (9)
Archive: Volume 17, 2025
Consequences of Canada’s Drug Agency Reimbursement Recommendations for New Medicines and Pan-Canadian Pharmaceutical Alliance Price Negotiations on Patient Access
Rawson NSB
ClinicoEconomics and Outcomes Research 2025, 17:975-989
Published Date: 23 December 2025
Substantial Increase in the Costs of Antineoplastic Agents in the USA from 2010 to 2021
Althemery AU
ClinicoEconomics and Outcomes Research 2025, 17:965-974
Published Date: 18 December 2025
Cost-Utility Analysis of Renal Replacement Therapy Modalities in the Management of Severe Acute Kidney Injury in US Critically Ill Patients
Martins R, Koyner J, Wald R, Harenski K, Echeverri J
ClinicoEconomics and Outcomes Research 2025, 17:931-944
Published Date: 15 December 2025
Analysis of Cost-Effectiveness of Biologic Therapies in Axial Spondyloarthritis Based on Real-World Data
Al-Saleh J, Negm AA, Almarzooqi A, Elsidig NEE, Zamani N
ClinicoEconomics and Outcomes Research 2025, 17:915-930
Published Date: 13 December 2025
Awareness and Sociodemographic Factors as Predictors of Knowledge About Health Economics and Pharmacoeconomics Among Registered Nurses: A Cross-Sectional Study
Alanazi HI, Tumala RB, Asiri MY, Alharbi HA, Alenazy BA, Al-Ghareeb SA, Alsmari AA, Alsbaie MA
ClinicoEconomics and Outcomes Research 2025, 17:897-913
Published Date: 12 December 2025
Cost-Utility Analyses of Hemodialysis, Peritoneal Dialysis, and Kidney Transplantation in Patients with End-Stage Kidney Disease: A Systematic Review
Wulandari W, Alfaqeeh M, Zakiyah N, Shafie AA, Suwantika AA
ClinicoEconomics and Outcomes Research 2025, 17:883-895
Published Date: 5 December 2025
Are Nutritional Interventions Worthwhile in Cancer Patients? A Systematic Review on Economic Evaluation
Nguyen HTT, Riewpaiboon A, Tran HTB, Youngkong S, Vo TQ, Turongkaravee S
ClinicoEconomics and Outcomes Research 2025, 17:865-882
Published Date: 2 December 2025
Comparative Effectiveness of DHIS2 and FAIR Data Approaches for Privacy-Preserving Health Data Analytics in Uganda: A Systematic Review
Basajja M, Paul-Chima UO
ClinicoEconomics and Outcomes Research 2025, 17:849-864
Published Date: 18 November 2025
Cost-Effectiveness Analysis of Different Prenatal Screening Strategies for the Prevention of Severe Thalassemia in Thailand
Malasai K, Jittikoon J, Talungchit P, Youngkong S, Udomsinprasert W, Chaikledkaew U
ClinicoEconomics and Outcomes Research 2025, 17:835-848
Published Date: 15 November 2025
Healthcare Resource Utilization and Cost Implications of Commercial Blenderized versus Plant-Based Standard Enteral Formulas in Children and Adults in Post-Acute Care: A Retrospective Study
Bennett K, Desai A, Henrikson A, Cekola P, Liu J, Kumar P, Klosterbuer A, Araujo Torres K
ClinicoEconomics and Outcomes Research 2025, 17:821-833
Published Date: 12 November 2025
Cost-Effectiveness Analysis and Priority Setting in the Transition from Iron-Folic Acid (IFA) to Multiple Micronutrient Supplementation (MMS) for Pregnant Women in Indonesia
Alfiani F, Utami AM, Zakiyah N, Daud NAA, Suwantika AA, Puspitasari IM
ClinicoEconomics and Outcomes Research 2025, 17:809-820
Published Date: 11 November 2025
A Method for Adjusting EQ-5D-3L Health State Utilities for Cross-Country Use: Application of a Novel US-to-UK Utility Mapping Approach
Omar Alsaleh AJ, Msihid J, Lew E, Nicholls C
ClinicoEconomics and Outcomes Research 2025, 17:797-808
Published Date: 4 November 2025
Prices of Anti-Diabetic Drugs Sold in Private Pharmacies in Côte d’Ivoire, 2023: A Secondary Analysis
Attia Konan AR, Koffi K, Hounsa Alla EA, Sindé AJM, Sackou Kouakou JG
ClinicoEconomics and Outcomes Research 2025, 17:789-796
Published Date: 29 October 2025
Cost-Effectiveness of Once-Weekly Insulin Icodec versus Daily Basal Insulins in Chinese Adults with T2DM: A Treatment-Background Stratified Analysis
Xie Z, Deng W, Liang Z, Xie Y, Chen J, Cao W
ClinicoEconomics and Outcomes Research 2025, 17:771-787
Published Date: 27 October 2025
The HIV Epidemic in the United States – Epidemiological Projections and Public Economic Impact of Achieving Zero Transmission Goals
Copeland C, Martins R, Thaliffdeen R, Kotsopoulos N, Jarrett J, Chaudhari P, Mordi U, Postma MJ
ClinicoEconomics and Outcomes Research 2025, 17:755-769
Published Date: 23 October 2025
Retrospective Study of Real-World Treatment Patterns of Subcutaneous Semaglutide Use Among Patients with Metabolic Dysfunction-Associated Steatohepatitis in the United States
Kim Y, Zeng N, Winer-Jones JP, Bonafede M, Lobo F, O’Donnell J, Ryan T
ClinicoEconomics and Outcomes Research 2025, 17:743-754
Published Date: 22 October 2025
A Systematic Literature Review of Real-World Treatment Effectiveness and Economic and Humanistic Burden in Patients With Muscle-Invasive Bladder Cancer Who Underwent Radical Cystectomy
Shih V, Yin L, Theodorou E, Dillon R, Brancato SJ, Hamilton L, Wirtz HS
ClinicoEconomics and Outcomes Research 2025, 17:729-742
Published Date: 21 October 2025
Budget Impact Analysis of Botulinum Toxin Type A for Patients with Severe Blepharospasm in Thailand
Hirunwiwatkul P, Permsuwan U, Ngamkiatphaisan S, Chirapapaisan N, Sriratanaban J
ClinicoEconomics and Outcomes Research 2025, 17:717-728
Published Date: 11 October 2025
Retrospective Database Analysis of the Clinical and Economic Outcomes Associated with Disruptive Surgical Bleeding
Afolabi M, N V P, Kumar A, Danker III WA, Johnston SS
ClinicoEconomics and Outcomes Research 2025, 17:705-716
Published Date: 5 October 2025
Prevalence & Economic Burden of Adult Spinal Deformity in a Large United States Commercial Payer Population
Koltsov JC, Ackerman SJ, McFarlane KH, Mehta S, Brown M, Gardner MJ, Hu SS, Polly DW Jr
ClinicoEconomics and Outcomes Research 2025, 17:687-704
Published Date: 3 October 2025
Improving Efficiency and Safety with Prefilled Syringes: A Model-Based Economic Evaluation for US Healthcare Settings
Borms M, Taneja A, Weiss M, Girgis H, Frolet C, Lucaci JD
ClinicoEconomics and Outcomes Research 2025, 17:673-685
Published Date: 4 October 2025
Economic Evaluation of Molecular Testing for Pulmonary Tuberculosis Diagnosis: A Systematic Review
Chitpim N, Yoopetch P, Jittikoon J, Udomsinprasert W, Bunwong K, Mahasirimongkol S, Chaikledkaew U
ClinicoEconomics and Outcomes Research 2025, 17:661-671
Published Date: 1 October 2025
Cost Assessment of Pediatric Haploidentical Hematopoietic Stem Cell Transplantation
Achour L, Fazaa I, Drira C, Trabelsi Y, Ouederni M, Fradi I
ClinicoEconomics and Outcomes Research 2025, 17:653-659
Published Date: 30 September 2025
Determinants of Economic Costs Following Road Traffic Injuries in Canada: A Quantile Regression Forests Machine Learning Approach
Momenyan S, Chan H, Jae L, Taylor JA, Staples JA, Harris DR, Brubacher JR
ClinicoEconomics and Outcomes Research 2025, 17:639-652
Published Date: 10 September 2025
Beyond the COVID-19 Pandemic: Budget Impact Analysis of Remote Healthcare Delivery for Hypertension and Diabetes Mellitus Management in Thailand
Chongpornchai J, Phodha T, Wongphan T, Soonklang K, Coyte PC
ClinicoEconomics and Outcomes Research 2025, 17:627-638
Published Date: 29 August 2025
Early Diagnosis and Timely Terlipressin in Hepatorenal Syndrome Improves Projected Outcomes and Lowers Cost
Gallegos-Orozco JF, O’Leary JG, Reddy KG, Bindra J, Chopra I, Niewoehner J, Huang X
ClinicoEconomics and Outcomes Research 2025, 17:615-625
Published Date: 29 August 2025
Willingness of Urban Formal Sector Workers to Support a Community-Based Health Insurance Scheme in Ethiopia
Mebratie AD, Shamebo D, Alemu G, Shigute Z, Bedi AS
ClinicoEconomics and Outcomes Research 2025, 17:601-613
Published Date: 28 August 2025
Real-World Disability Outcomes Among Patients Treated with Cariprazine vs Other Atypical Antipsychotics as Adjunctive Treatment for Major Depressive Disorder
Masand PS, Parikh M, Ta JT, Wade SW, Haile F, Ripley S, Zanardo E, Spencer CS, Laliberté F, Nabulsi N
ClinicoEconomics and Outcomes Research 2025, 17:585-600
Published Date: 28 August 2025
Healthcare Utilization and Cost in the Two Years Before Neuromodulation Implantation Among Medicaid Enrollees with Drug-Resistant Epilepsy
Evans K, Li Q, Zhang L, Lam S, Do Rego B, Danielson V, Lassagne R, Berger A
ClinicoEconomics and Outcomes Research 2025, 17:571-583
Published Date: 28 August 2025
Trends, Patient Outcomes, and Resource Utilization Associated with Surgical Staplers During Robotic Sleeve Gastrectomy
Pan IW, Siddiqui ZA
ClinicoEconomics and Outcomes Research 2025, 17:561-569
Published Date: 22 August 2025
Exploring Psychosocial and Economic Support for Children with HIV/AIDS: Perspectives of Health and Community Workers in the Katuba Health Zone, Lubumbashi
Diyoka CK, Kaj FM, Mwanvua LN, Mukanya MM, Bukasa PK, Lambo GN, Mjumbe CK
ClinicoEconomics and Outcomes Research 2025, 17:547-559
Published Date: 22 August 2025
Clinical Burden and Costs of Anti-Neutrophil Cytoplasmic Antibody-ANCA-Associated Vasculitis: Main Findings from REDCap Registry of a University Hospital in Spain
Draibe J, Martinez Valenzuela L, Gomez-Preciado F, Anton-Pampols P, Rau AM, Díaz-Cuervo H, Crespo C, Cuervo J, Ramirez de Arellano A
ClinicoEconomics and Outcomes Research 2025, 17:537-546
Published Date: 1 August 2025
Economic Impact of Elranatamab for Treatment of Patients with Relapsed or Refractory Multiple Myeloma [Letter]
Gupta-Werner N, Goble J, Slavcev M
ClinicoEconomics and Outcomes Research 2025, 17:535-536
Published Date: 30 July 2025
Cost-Utility Analysis of Metabolic Bariatric Surgery for Individuals with Obesity in Saudi Arabia
Nagi MA, Turongkaravee S, Almalki ZS, Thavorncharoensap M, Sangroongruangsri S, Chaikledkaew U, Alqahtani AM, AlSharif LS, Alsubaihi IA, Alzarea AI, Alsultan MM
ClinicoEconomics and Outcomes Research 2025, 17:519-533
Published Date: 23 July 2025
Enhancing Patient Safety and Charge Capture Through Smart Infusion Pump Interoperability: A Health Economic Analysis for US Health Systems
Borrelli EP, Taneja A, Abdallah S, Weiss M, Wilson NS, Beer I, Lucaci JD
ClinicoEconomics and Outcomes Research 2025, 17:507-518
Published Date: 22 July 2025
Healthcare Costs and Treatment Patterns of Triplet Therapies in Relapsed/Refractory Multiple Myeloma: Real World Evidence from Italy
Perrone V, Leogrande M, Giacomini E, Cappuccilli M, Degli Esposti L
ClinicoEconomics and Outcomes Research 2025, 17:495-505
Published Date: 19 July 2025
Adding Tolvaptan in the Inpatient Treatment for Patients with Heart Failure and Hyponatremia: Budget Impact Analysis in Thailand
Permsuwan U, Leemasawat K, Arunmanakul P
ClinicoEconomics and Outcomes Research 2025, 17:485-494
Published Date: 16 July 2025
Evaluating the Economic Impact of Diabetes Mellitus: A Hospital-Centric Cost Analysis in Hail, Saudi Arabia
Alshammari AM, Elnaem MH, Ong SC
ClinicoEconomics and Outcomes Research 2025, 17:473-484
Published Date: 15 July 2025
Comparative Cost Analysis for Direct Medical Costs of Protocol Administration of Non-Small Cell Lung Cancer Treatment Regimens in Curative Intent: A Micro-Costing Study in Jordan
Madae’en SS, Salem AA, Ararawi NS, Ramzi EJ, Aloueedat RF, Saabenh AM, Allouzi DA, Abuoudeh RH, Hnaif OE, Musa LM, Alshdaifat SH, Al-Tanashat AJ, Almasa’afeh HY, Abuallaban SM
ClinicoEconomics and Outcomes Research 2025, 17:455-471
Published Date: 12 July 2025
Medicare Savings for Seizure Drugs by Adopting the Mark Cuban Cost Plus Drug Company Model
Smith T, Young A, O’Brien C, Duncan J, Rashid M, Magee T, Fitzgerald K, Vassar M
ClinicoEconomics and Outcomes Research 2025, 17:447-453
Published Date: 18 June 2025
The Economic Burden of Patients with Diabetic Peripheral Neuropathic Pain Based on a Real-World Study in China
Wang R, Xuan DD, Xuan J, Dai D, Ye X, Hu X
ClinicoEconomics and Outcomes Research 2025, 17:437-446
Published Date: 13 June 2025
The Social Cost of Nasal Sequelae in Patients with Cleft Lip and Palate in a Peruvian University Dental Clinic
Córdova-Aguilar A, Ramos W, Blanco-Victorio DJ, López-Ramos RP, Best Bandenay PY, Castañeda Saldaña E, De La Cruz-Vargas JA
ClinicoEconomics and Outcomes Research 2025, 17:429-436
Published Date: 9 June 2025
Time-Driven Activity-Based Costing for Cervical Myelopathy Surgery: A Step Towards Total Episode Costs
Keppetipola KM, Leibold A, Trivedi J, Kabani AS, Sarikonda A, Self DM, Isch EL, Glener S, Prasad S, Jallo J, Heller JE, Harrop J, Vaccaro AR, Sivaganesan A
ClinicoEconomics and Outcomes Research 2025, 17:419-428
Published Date: 3 June 2025
Evaluating the Fiscal Impact of Antiretroviral Therapy for the Management of HIV in the United States 1987–2023
Paquete AT, Mordi U, Jarrett J, Thaliffdeen R, Chaudhari P, Connolly MP, Kotsopoulos N, Sullivan PS
ClinicoEconomics and Outcomes Research 2025, 17:407-418
Published Date: 28 May 2025
Health Economics Evaluation of Bictegravir/Emtricitabine/Tenofovir for a First-Line Treatment of HIV-1 Infection in China
Wang W, Zhou D, Zhou K, Zhang D, Li H, Zhang H, Jiang X, Wang R, Wang X, Tang W
ClinicoEconomics and Outcomes Research 2025, 17:393-406
Published Date: 23 May 2025
Budget Impact of Shifting the Treatment Setting of Unresectable Liver Metastases Associated with Primary Colorectal Cancer Using Y-90 Resin Microspheres from the Outpatient Hospital to the Office-Based Laboratory
Sperling DC, Wallace K, von Oppen N, Weintraub JL
ClinicoEconomics and Outcomes Research 2025, 17:387-392
Published Date: 8 May 2025
Cost-Effectiveness of a Community First Responder System for Out-of-Hospital Cardiac Arrest in Poland
Jaskuła J, Medic G, Verma S, Maurer J, Kooy TA, Greef BD
ClinicoEconomics and Outcomes Research 2025, 17:375-386
Published Date: 2 May 2025
Comprehensive Insights into the Economic Burden of Rheumatoid Arthritis in Latin America: A Systematic Literature Review of Regional Perspectives
Maldonado-Restrepo AI, Acelas-Gonzalez GE, Rodríguez-Vargas GS, Rodriguez-Linares P, Gonzalez-Rodriguez JL, Rojas-Villarraga A, Santos-Moreno P
ClinicoEconomics and Outcomes Research 2025, 17:349-373
Published Date: 17 April 2025
A Cost-Effectiveness Analysis of Mosunetuzumab vs Tisagenlecleucel for Treatment of Third- or Higher-Line (3L+) Relapsed or Refractory (R/R) Follicular Lymphoma (FL) in Italy
Luminari S, Pinto A, Puccini B, D’Arpino A, Omodeo Salè E, Bellone M, Pradelli L, Sabinot A
ClinicoEconomics and Outcomes Research 2025, 17:335-348
Published Date: 16 April 2025
Cost-Minimization Analysis and Budget Impact Analysis About Subcutaneous Natalizumab in Relapsing-Remitting Multiple Sclerosis in Italy
Prosperini L, Pradelli L, Santoni L, Perini D, Cottone S, Vercellino M
ClinicoEconomics and Outcomes Research 2025, 17:315-333
Published Date: 11 April 2025
Clinical and Economic Burden of Managing Patients with Sickle Cell Disease Receiving Frequent Red Blood Cell Transfusions in the United States
Udeze C, Jerry M, Evans KA, Li N, Jain S, Andemariam B
ClinicoEconomics and Outcomes Research 2025, 17:303-313
Published Date: 11 April 2025
Economic Impact of Elranatamab for Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Shah B, Sandin R, Liu Y, Bobolts LR, Hu Y, Mol I, Schepart A, Hughes DM, Hart J, Hlavacek P
ClinicoEconomics and Outcomes Research 2025, 17:289-302
Published Date: 8 April 2025
The Impact of Obesity-Related Complications on Healthcare Costs – Outcomes of a Pharmacoeconomic Weight Loss Model
Yilmaz ES, Malhan S, Gurser B, Gogas Yavuz D
ClinicoEconomics and Outcomes Research 2025, 17:277-287
Published Date: 5 April 2025
Cost-Effectiveness of Oral Nutritional Supplements in Malnourished or at Risk of Disease-Related Malnutrition Cancer Patients in North Macedonia
Kapedanovska Nestorovska A, Sterjev Z
ClinicoEconomics and Outcomes Research 2025, 17:265-276
Published Date: 26 March 2025
Healthcare Resource Utilization and Cost Comparison Between Palbociclib, Abemaciclib, and Ribociclib Among Patients with HR+/HER2− Metastatic Breast Cancer
Pluard TJ, Sandin R, Parikh RC, Ward MA, Stansfield L, Nham T, Esterberg E, Cha-Silva AS, Shah B
ClinicoEconomics and Outcomes Research 2025, 17:247-264
Published Date: 26 March 2025
The Burden of Obesity in Saudi Arabia: A Real-World Cost-of-Illness Study
Nagi MA, Almalki ZS, Thavorncharoensap M, Sangroongruangsri S, Turongkaravee S, Chaikledkaew U, Alqahtani AM, AlSharif LS, Alsubaihi IA, Alzarea AI, Alsultan MM
ClinicoEconomics and Outcomes Research 2025, 17:233-246
Published Date: 21 March 2025
Cost-Effectiveness Analysis of Ofatumumab versus Teriflunomide for Relapsing-Remitting Multiple Sclerosis: A 10-Year Markov Model
Almalki ZS, Alshammari MM, Almazrou SH, Alqahtani OAA, Alkhayat MR, Alnemari SF, Mukhemair HS, Alkredeas SM, Alsuhibani AA, Asiri BY, Alalawi TN, Alahmari AK, Alotaibi FO
ClinicoEconomics and Outcomes Research 2025, 17:217-232
Published Date: 20 March 2025
Patient Experiences with the Impacts of Multiple Sclerosis & Disease-Modifying Therapies
Talente B, Finseth LT, Blake N, Costello K, Schmidt H, Vandigo J, Oehrlein EM
ClinicoEconomics and Outcomes Research 2025, 17:199-215
Published Date: 15 March 2025
The Budget Impact of Cangrelor in the UK for the Treatment of Out-of-Hospital Cardiac Arrest Patients Who Require Percutaneous Coronary Intervention
Modi B, Cain R, Stork R, Barwood C, Tarpey G, Colucciello A
ClinicoEconomics and Outcomes Research 2025, 17:189-197
Published Date: 15 March 2025
Economic Burden of Intravenous Decitabine Administration in Patients Affected by Acute Myeloid Leukemia Ineligible for Induction Chemotherapy and Impact of Oral Formulation Introduction: A Micro-Costing Study in Italy
Di Costanzo A, Loreto L, Vassallo C, Fiorentino F
ClinicoEconomics and Outcomes Research 2025, 17:171-187
Published Date: 13 March 2025
Cost-Effectiveness Analysis for Managing Diabetic Foot Ulcer (DFU) in USA: Platelet-Rich Plasma (PRP) vs Standard of Care (SoC)
Russo S, Landi S, Simoni S
ClinicoEconomics and Outcomes Research 2025, 17:157-169
Published Date: 8 March 2025
Real World Evidence on Hormone Receptor Positive and Human Epidermal Growth Factor Receptor 2 Negative Metastatic Breast Cancer in Italy: Insights From 2017 to 2021 Data
Perrone V, Leogrande M, Cappuccilli M, Saragoni S, Cinti Luciani A, Degli Esposti L
ClinicoEconomics and Outcomes Research 2025, 17:147-155
Published Date: 6 March 2025
Dose Escalation Patterns and Associated Costs of Advanced Therapies for Ulcerative Colitis in France and the United Kingdom: A Retrospective Database Analysis
Treuer T, Richards M, Mert C, Dhesi E, Silva L, Tan Y, Hoque S
ClinicoEconomics and Outcomes Research 2025, 17:129-146
Published Date: 1 March 2025
Sensitivity of Cost-Effectiveness to Inclusion of Adverse Drug Events: A Scoping Review of Economic Models of Pharmacological Interventions for Diabetes, Diabetic Retinopathy, and Diabetic Macular Edema
Pesonen M, Kankaanpää E
ClinicoEconomics and Outcomes Research 2025, 17:115-128
Published Date: 26 February 2025
Using QIP-MS to Guide the Timing of MRD Testing in Patients With Multiple Myeloma: A Budget Impact Analysis From the French Payer Perspective
Siegfried C, Amarapala M, Leleu X, Fusfeld L
ClinicoEconomics and Outcomes Research 2025, 17:107-114
Published Date: 20 February 2025
Budget Impact and Cost–Benefit Analyses of Sodium-Glucose Cotransporter-2 Inhibitors for Patients With Heart Failure in Thailand
Arunmanakul P, Phodha T, Pinta-ay S, Nimworapan M, Phrommintikul A, Thammatacharee N, Dilokthornsakul P
ClinicoEconomics and Outcomes Research 2025, 17:95-105
Published Date: 17 February 2025
Real World Evaluation of Next-Day Molecular Respiratory Infectious Disease Testing on Healthcare Resource Utilization and Costs
French AJ, Fragala MS, Evans AS, Upadhyay P, Goldberg SE, Reddy J
ClinicoEconomics and Outcomes Research 2025, 17:79-93
Published Date: 11 February 2025
Atopic Dermatitis Treatments Before and After Initiation of Ruxolitinib Cream: 6-Month Follow-Up Analysis of a US Payer Claims Database
Liu J, Desai K, Teng CC, Sturm D, Stockbower G, Patadia H, Willey V
ClinicoEconomics and Outcomes Research 2025, 17:69-77
Published Date: 6 February 2025
Estimating the Cost-Effectiveness of Tumor Treating Fields (TTFields) Therapy with an Immune Checkpoint Inhibitor or Docetaxel in Metastatic Non-Small Cell Lung Cancer
Furnback W, Wu E, Koh CYC, Nino de Rivera Guzman JF, Kruhl C, Kotecha R, Wang BC
ClinicoEconomics and Outcomes Research 2025, 17:55-68
Published Date: 5 February 2025
Financial Cost of Treating Polytrauma in a Public Tertiary Hospital in the South-Eastern Democratic Republic of Congo: A Case Series Study
Kabeya Diyoka C, Ngongo Mwanvua L, Shauri Kalemera M, Pambi Mukanga P, Koba Mjumbe C
ClinicoEconomics and Outcomes Research 2025, 17:45-54
Published Date: 4 February 2025
Cost-Benefit Analysis of Genetic Testing as a Prenatal Diagnostic Tool for Thalassemia: A Single-Center Study From Central Thailand
Malasai K, Jittikoon J, Udomsinprasert W, Talungchit P, Youngkong S, Sangroongruangsri S, Mahasirimongkol S, Chaikledkaew U
ClinicoEconomics and Outcomes Research 2025, 17:33-43
Published Date: 4 February 2025
The Comparison of Cost-Effectiveness Between Magnetic Resonance Spectroscopy and Provocative Discography in the Identification of Chronic Low Back Pain Surgery Candidates
Wilson L, Beall DP, Eastlack RK, Berven S, Lotz JC
ClinicoEconomics and Outcomes Research 2025, 17:19-31
Published Date: 23 January 2025
A Novel Model Using ML Techniques for Clinical Trial Design and Expedited Patient Onboarding Process
Iyer A, Narayanaswami S
ClinicoEconomics and Outcomes Research 2025, 17:1-18
Published Date: 16 January 2025